Cargando…

Impact of Infusion Therapies on Quality of Life in Advanced Parkinson’s Disease

A high burden of motor and non-motor parkinsonian symptoms is known to have a significant negative impact on the quality of life (QoL) of people with Parkinson’s disease (PD). Effective control of these symptoms with therapies that enable patients to maintain a good QoL is therefore a key treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Constantin, Viorelia A, Szász, József A, Dulamea, Adriana Octaviana, Valkovic, Peter, Kulisevsky, Jaime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506606/ https://www.ncbi.nlm.nih.gov/pubmed/37727253 http://dx.doi.org/10.2147/NDT.S422717

Ejemplares similares

Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis
por: Simu, Mihaela Adriana, et al.
Publicado: (2021)

Characterizing Advanced Parkinson's Disease: Romanian Subanalysis from the OBSERVE-PD Study
por: Szasz, Jozsef Attila, et al.
Publicado: (2021)

The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies
por: Dulamea, Adriana Octaviana
Publicado: (2017)

Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Observations and Dilemmas after 10 Years of Real-Life Experience
por: Szász, József Attila, et al.
Publicado: (2022)

Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson’s Disease
por: Szász, József Attila, et al.
Publicado: (2021)

Neurological complications of hematopoietic cell transplantation in children and adults
por: Dulamea, Adriana Octaviana, et al.
Publicado: (2018)

Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients
por: Szász, József Attila, et al.
Publicado: (2019)

Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients
por: Constantin, Viorelia Adelina, et al.
Publicado: (2020)

N°255 – De nuovo status epilepticus in acute COVID-19 infection in an elderly woman
por: Arbune, Anca Adriana, et al.
Publicado: (2023)

Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients
por: Szász, József Attila, et al.
Publicado: (2019)

Nonmotor Symptoms in Early- and Advanced-Stage Parkinson's Disease Patients on Dopaminergic Therapy: How Do They Correlate with Quality of Life?
por: Valkovic, Peter, et al.
Publicado: (2014)

Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review
por: Volkmann, Jens, et al.
Publicado: (2013)

Neurological and Dermatological Manifestations of Tuberous Sclerosis Complex: Report from a Romanian Tertiary Hospital Cohort
por: Dulamea, Adriana Octaviana, et al.
Publicado: (2023)

Case Report: Hyponatremia Secondary to Desmopressin Administration Prior to Percutaneous Kidney Biopsy: A Case-Based Review
por: Vornicu, Alexandra, et al.
Publicado: (2021)

Tratamientos complementarios en la enfermedad de Parkinson
por: Kulisevsky, Jaime
Publicado: (2004)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

Pharmacological management of Parkinson’s disease motor symptoms: update and recommendations from an expert
por: Kulisevsky, Jaime
Publicado: (2022)

Parkinson's Disease: From Genetics to Clinical Practice
por: Clarimón, Jordi, et al.
Publicado: (2013)

Transtornos cognitivos y neuropsiquiátricos en la enfermedad de Parkinson /
por: Kulisevsky Bojarski, Jaime
Publicado: (2003)

The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
por: Băjenaru, O., et al.
Publicado: (2015)

Tuberous sclerosis with negative genetic testing and multiple cerebral cavernomas: A new association (Case report)
por: Arbune, Anca Adriana, et al.
Publicado: (2021)

The Impact of Kidney Biopsy for Fabry Nephropathy Evaluation on Patients’ Management and Long-Term Outcomes: Experience of a Single Center
por: Rusu, Elena-Emanuela, et al.
Publicado: (2022)

Tratamiento farmacológico de los síntomas motores de la enfermedad de Parkinson: actualización y recomendaciones de un experto
por: Kulisevsky, Jaime
Publicado: (2022)

Autologous mesenchymal stem cells applied on the pressure ulcers had produced a surprising outcome in a severe case of neuromyelitis optica
por: Dulamea, Adriana Octaviana, et al.
Publicado: (2015)

The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson’s Disease
por: Pintér, Dávid, et al.
Publicado: (2020)

Consensus on the Definition of Advanced Parkinson's Disease: A Neurologists-Based Delphi Study (CEPA Study)
por: Luquin, Maria-Rosario, et al.
Publicado: (2017)

Infusion Therapies in the Treatment of Parkinson’s Disease
por: van Laar, Teus, et al.
Publicado: (2023)

Long-term Efficacy of Safinamide on Parkinson’s Disease Chronic Pain
por: Cattaneo, Carlo, et al.
Publicado: (2018)

Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study
por: Meira, Bruna, et al.
Publicado: (2021)

Validation of a simple screening tool for early diagnosis of advanced Parkinson’s disease in daily practice: the CDEPA questionnaire
por: Martinez-Martin, Pablo, et al.
Publicado: (2018)

Impact of Duodopa on Quality of Life in Advanced Parkinson's Disease: A UK Case Series
por: Foltynie, T., et al.
Publicado: (2013)

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden
por: Modugno, Nicola, et al.
Publicado: (2020)

Impact of Sex on the Nonmotor Symptoms and the Health-Related Quality of Life in Parkinson's Disease
por: Kovács, Márton, et al.
Publicado: (2016)

Pain in Parkinson´s Disease: A Cross-Sectional Study of Its Prevalence, Types, and Relationship to Depression and Quality of Life
por: Valkovic, Peter, et al.
Publicado: (2015)

The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
por: Aracil‐Bolaños, Ignacio, et al.
Publicado: (2021)

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden [Corrigendum]
Publicado: (2021)

Current and novel infusion therapies for patients with Parkinson's disease
por: Antonini, Angelo, et al.
Publicado: (2023)

The Impact of Dysphagia Therapy on Quality of Life in Patients with Parkinson's Disease as Measured by the Swallowing Quality of Life Questionnaire (SWALQOL)
por: Ayres, Annelise, et al.
Publicado: (2016)

Challenges in Cerebral Venous Thrombosis Management—Case Reports and Short Literature Review
por: Pleșa, Florentina Cristina, et al.
Publicado: (2023)

Impact of Anxiety on Quality of Life in Parkinson's Disease
por: Hanna, Kristine K., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_30fa9mqkqo6copku20g8n7lv1f